# Environmentally activatable hydrogel for spatiotemporally programmed nitric oxide delivery for diabetic wound healing

**Authors:** Langjie Chai, Yiran Shi, Qianqian Li, Yifan Han, Liangcong Hu, Yifeng Lei, Liang Guo

PMC · DOI: 10.1016/j.mtbio.2026.102916 · 2026-02-10

## TL;DR

A smart hydrogel that releases nitric oxide on demand is developed to improve healing in diabetic wounds.

## Contribution

An environmentally activatable hydrogel for spatiotemporally controlled nitric oxide delivery is engineered for diabetic wound healing.

## Key findings

- The CS-SNAP hydrogel enables sustained nitric oxide release over 300 minutes via ambient light and temperature modulation.
- The hydrogel promotes M1-to-M2 macrophage polarization and exhibits antibacterial and angiogenic properties.
- The platform shortens the inflammatory phase and accelerates diabetic wound healing.

## Abstract

Nitric oxide (NO) plays a central role in wound healing, by regulating vascular homeostasis, inflammation, and antimicrobial effects. However, chronic diabetic wounds are difficult to heal due to the hyperglycemic microenvironment, which reduces endogenous NO production. Therefore, developing intelligent dressings capable of spatiotemporally programmed NO delivery holds great promise in promoting diabetic wound healing. Herein, we engineered an environmentally activatable hydrogel that enabled on-demand NO release for diabetic wound healing. The CS-SNAP hydrogel was achieved by covalent grafting of NO donor (S-nitroso-N-acetylpenicillamine, SNAP) onto the matrix of carboxymethyl chitosan methacryloyl (CMCSMA), and by subsequent fast photopolymerization during only 10 s. The CS-SNAP hydrogel enabled sustained release of NO over 300 min by simply modulating ambient light and temperature. When applied to diabetic wounds, not only did the CS-SNAP hydrogel exhibit effective antibacterial activity, but it also showed good angiogenic ability and promoted M1-to-M2 polarization of macrophages. Together, this environmentally activatable platform demonstrates great potential to shorten the inflammatory phase of diabetic wounds, prevent bacterial colonization, and accelerates diabetic wound healing.

Image 1

## Linked entities

- **Chemicals:** Nitric oxide (PubChem CID 145068), S-nitroso-N-acetylpenicillamine (PubChem CID 5231)

## Full-text entities

- **Genes:** Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 59086] {aka Tgfb}, Il10 (interleukin 10) [NCBI Gene 25325] {aka IL10X, If2a}, Lap3 (leucine aminopeptidase 3) [NCBI Gene 289668] {aka LAP-3}, Cs (citrate synthase) [NCBI Gene 170587], Gucy1b2 (guanylate cyclase 1 soluble subunit beta 2) [NCBI Gene 25206] {aka Gucy1b2a, Gucy1b2b, SGC}, Pecam1 (platelet and endothelial cell adhesion molecule 1) [NCBI Gene 29583] {aka CD31, Pecam}, Hif1a (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 29560] {aka HIF1-alpha, MOP1}, Vegfa (vascular endothelial growth factor A) [NCBI Gene 83785] {aka VEGF-A, VEGF111, VEGF164, VPF, Vegf}, Cd86 (CD86 molecule) [NCBI Gene 56822] {aka B7-2}
- **Diseases:** hypoxia (MESH:D000860), hemolysis (MESH:D006461), phototoxicity (MESH:D017484), Diabetic (MESH:D003920), chronic inflammation (MESH:D007249), Chronic wounds (MESH:D014947), necrosis (MESH:D009336), chronic (MESH:D002908), type I diabetic (MESH:D003922), infected (MESH:D007239), cardiovascular diseases (MESH:D002318), cytotoxicity (MESH:D064420), wound infection (MESH:D014946), diabetic ulcer (MESH:D017719), hyperglycemic (MESH:D006944)
- **Chemicals:** NO3- (MESH:C038619), acetic acid (MESH:D019342), S-nitrosothiols (MESH:D026403), Blood glucose (MESH:D001786), NO (MESH:D009569), ethanol (MESH:D000431), water (MESH:D014867), amide (MESH:D000577), N-hydroxysuccinimide (MESH:C001426), CCK-8 (MESH:D012844), STZ (MESH:D013311), Griess reagent (MESH:C095000), N (MESH:D009584), NO2- (MESH:D009585), polymer (MESH:D011108), sodium nitrite (MESH:D012977), C (MESH:D002244), S-nitroso-N-acetylpenicillamine (MESH:D026423), streptomycin (MESH:D013307), Triton-X (MESH:D017830), chitin (MESH:D002686), agar (MESH:D000362), Saline (MESH:D012965), methanol (MESH:D000432), cGMP (MESH:D006152), Calcein AM (MESH:C085925), O (MESH:D010100), Chitosan (MESH:D048271), nitrate (MESH:D009566), lithium phenyl(2,4,6-trimethylbenzoyl)phosphinate (MESH:C546776), PBS (MESH:D007854), sevoflurane (MESH:D000077149), EDC (MESH:C024565), ice (MESH:D007053), 4',6-diamidino-2-phenylindole (MESH:C007293), CO2 (MESH:D002245), CS (MESH:D002586), diazeniumdiolates (MESH:C452539), nitrite (MESH:D009573), N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide (MESH:C569779), H&amp;E (MESH:D006371), S (MESH:D013455), crystal violet (MESH:D005840), CMCSMA (-), propidium iodide (MESH:D011419), penicillin (MESH:D010406)
- **Species:** Pseudomonas aeruginosa (species) [taxon 287], Mus musculus (house mouse, species) [taxon 10090], Escherichia coli (E. coli, species) [taxon 562], Staphylococcus aureus (species) [taxon 1280], Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** HSF — Homo sapiens (Human), Finite cell line (CVCL_A9FC), HUVEC — Homo sapiens (Human), Finite cell line (CVCL_2959)

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12925292/full.md

---
Source: https://tomesphere.com/paper/PMC12925292